|
|
Tenofovir/Emtricitabine Useful Add-On to Nevirapine for Perinatal HIV Prevention
|
| Link ID |
738 |
| Title |
Tenofovir/Emtricitabine Useful Add-On to Nevirapine for Perinatal HIV Prevention |
| Url |
http://www.medscape.com/viewarticle/565438?src=rss |
| Description |
In women given intrapartum nevirapine for prevention of perinatal HIV transmission, a single dose of tenofovir and emtricitabine can reduce the development of HIV resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) at 6 weeks post-delivery, new research shows. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Nov 14, 2007 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
HIV Treatment Access Increases, but Coverage Still Low
|
|
|
As of the end of 2007, close to 3 million HIV-infected individuals in low- and middle-income nations had access to antiretroviral drug therapy (ART), representing an increase of nearly 950,000 people who received ART last year. Reuters Health Information
|
|
|
